Literature DB >> 29163745

Possible Reversible Cerebral Vasoconstriction Syndrome Associated with Eucalyptus: Case Report.

Daniel Lapid1, Mohtashim Arbaab Qureshi1, Ihtesham Aatif Quresh1, Mohammed Rauf Afzal1, Alberto Maud1, Gustavo J Rodriguez1, Rakesh Khatri1.   

Abstract

BACKGROUND: Reversible cerebral vasoconstrictive syndrome (RCVS) has characteristic clinical features, brain imaging and Angiographic features. The majority of RCVS cases are associated with the use of antidepressants, polysubstance abuse, and nasal decongestants. We here present a case that highlights the use of eucalyptus herbs as a possible precipitant factor for RCVS formation. CASE
PRESENTATION: A 42-year-old woman presented to the emergency department with a tingling sensation on the right-hand side of her body and a two-week progressive throbbing severe holocranial headache radiating to the neck, with associated nausea, photophobia, and phonophobia. She denied any seizures and recent trauma or fevers. She was not taking scheduled medications, but she had used inhaling vapors obtained from boiling eucalyptus leaves to alleviate sinus congestion. Initial imaging revealed subarachnoid hemorrhage at bilateral posterior parietal convexity leading to her admission into the intensive care unit. Further work up disclosed the presence of findings consistent with RCVS.
CONCLUSION: In conclusion, we hereby postulate that some herbal remedies used in alternative medicine, including eucalyptus, could play a role in causing serotonergic symptoms including dizziness, diarrhea, and cerebral vasoconstriction. Understanding that eucalyptus has the potential to contribute to RCVS due to its serotoninergic activity may be of importance in the diagnosis and management of these patients.

Entities:  

Keywords:  Reversible cerebral vasoconstrictive syndrome (RCVS); herbs; serotonergic symptoms; vasoconstriction

Year:  2017        PMID: 29163745      PMCID: PMC5683022     

Source DB:  PubMed          Journal:  J Vasc Interv Neurol        ISSN: 1941-5893


  10 in total

1.  Recurrent thunderclap headache associated with reversible intracerebral vasospasm causing stroke.

Authors:  J W Sturm; R A Macdonell
Journal:  Cephalalgia       Date:  2000-03       Impact factor: 6.292

2.  Inhaled 1,8-cineole reduces inflammatory parameters in airways of ovalbumin-challenged Guinea pigs.

Authors:  Vasco P D Bastos; Antoniella S Gomes; Francisco J B Lima; Teresinha S Brito; Pedro M G Soares; João P M Pinho; Claudijane S Silva; Armênio A Santos; Marcellus H L P Souza; Pedro J C Magalhães
Journal:  Basic Clin Pharmacol Toxicol       Date:  2010-08-16       Impact factor: 4.080

Review 3.  Narrative review: reversible cerebral vasoconstriction syndromes.

Authors:  Leonard H Calabrese; David W Dodick; Todd J Schwedt; Aneesh B Singhal
Journal:  Ann Intern Med       Date:  2007-01-02       Impact factor: 25.391

4.  Evidence for the involvement of the monoaminergic system, but not the opioid system in the antidepressant-like activity of ellagic acid in mice.

Authors:  Chandrashekaran Girish; Vishnu Raj; Jayasree Arya; Sadasivam Balakrishnan
Journal:  Eur J Pharmacol       Date:  2012-02-24       Impact factor: 4.432

5.  Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors.

Authors:  Anne Ducros; Ursula Fiedler; Raphael Porcher; Monique Boukobza; Christian Stapf; Marie-Germaine Bousser
Journal:  Stroke       Date:  2010-09-30       Impact factor: 7.914

6.  Nimodipine for treatment of primary thunderclap headache.

Authors:  S-R Lu; Y-C Liao; J-L Fuh; J-F Lirng; S-J Wang
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

7.  The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients.

Authors:  Anne Ducros; Monique Boukobza; Raphaël Porcher; Mariana Sarov; Dominique Valade; Marie-Germaine Bousser
Journal:  Brain       Date:  2007-11-19       Impact factor: 13.501

8.  Therapy for acute nonpurulent rhinosinusitis with cineole: results of a double-blind, randomized, placebo-controlled trial.

Authors:  Wolfgang Kehrl; Uwe Sonnemann; Uwe Dethlefsen
Journal:  Laryngoscope       Date:  2004-04       Impact factor: 3.325

9.  Benign angiopathy of the central nervous system: cohort of 16 patients with clinical course and long-term followup.

Authors:  Rula A Hajj-Ali; Anthony Furlan; Alex Abou-Chebel; Leonard H Calabrese
Journal:  Arthritis Rheum       Date:  2002-12-15

10.  Effect of eucalyptus oil inhalation on pain and inflammatory responses after total knee replacement: a randomized clinical trial.

Authors:  Yang Suk Jun; Purum Kang; Sun Seek Min; Jeong-Min Lee; Hyo-Keun Kim; Geun Hee Seol
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-18       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.